Dover Corporation Peer Comparison
Metric | Value | Ranking | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $26.2 Billion | 8/11 | ETN $130.6B |
PH $80.7B |
ITW $77.8B |
EMR $63.3B |
CMI $44.5B |
IR $40.3B |
XYL $32.6B |
DOV $26.2B |
PNR $15.7B |
AOS $12.8B |
FELE $4.7B |
Gross Margin | 38% | 6/11 | EMR 47% |
ITW 43% |
PNR 40% |
IR 39% |
AOS 39% |
DOV 38% |
ETN 38% |
XYL 38% |
FELE 37% |
PH 36% |
CMI 25% |
Profit Margin | 13% | 6/11 | ITW 19% |
PNR 17% |
ETN 16% |
PH 15% |
AOS 15% |
DOV 13% |
FELE 11% |
IR 10% |
XYL 9% |
EMR 8% |
CMI 8% |
EBITDA margin | 21% | 8/11 | ITW 29% |
EMR 28% |
PNR 27% |
IR 26% |
PH 25% |
ETN 23% |
AOS 22% |
DOV 21% |
XYL 19% |
FELE 17% |
CMI 14% |
Quarterly Revenue | $2.2 Billion | 6/11 | CMI $8.8B |
ETN $6.4B |
PH $5.2B |
EMR $4.4B |
ITW $4.0B |
DOV $2.2B |
XYL $2.2B |
IR $1.8B |
PNR $1.1B |
AOS $1.0B |
FELE $543.3M |
Quarterly Earnings | $281.8 Million | 6/11 | ETN $993.0M |
PH $785.0M |
ITW $759.0M |
CMI $726.0M |
EMR $329.0M |
DOV $281.8M |
XYL $194.0M |
PNR $186.1M |
IR $185.0M |
AOS $156.2M |
FELE $59.1M |
Quarterly Free Cash Flow | $162.8 Million | 8/11 | PH $1.1B |
EMR $998.0M |
ETN $759.0M |
ITW $571.0M |
PNR $522.2M |
IR $283.1M |
XYL $215.0M |
DOV $162.8M |
AOS $34.5M |
FELE $26.1M |
CMI -$1.1B |
Trailing 4 Quarters Revenue | $8.5 Billion | 6/11 | CMI $34.2B |
ETN $24.1B |
PH $19.9B |
EMR $17.0B |
ITW $16.0B |
DOV $8.5B |
IR $7.0B |
XYL $6.4B |
PNR $4.1B |
AOS $3.9B |
FELE $2.0B |
Trailing 4 Quarters Earnings | $1.5 Billion | 6/11 | CMI $8.8B |
ETN $6.4B |
PH $5.2B |
EMR $4.4B |
ITW $4.0B |
DOV $2.2B |
XYL $2.2B |
IR $1.8B |
PNR $1.1B |
AOS $1.0B |
FELE $543.3M |
Quarterly Earnings Growth | 16% | 4/11 | XYL 111% |
ETN 33% |
PNR 22% |
DOV 16% |
PH 11% |
IR 3% |
CMI 1% |
ITW 1% |
AOS -1% |
FELE -2% |
EMR -96% |
Annual Earnings Growth | 62% | 2/11 | XYL 97% |
DOV 62% |
ETN 37% |
IR 25% |
PNR 22% |
PH 15% |
FELE 9% |
AOS 7% |
ITW 6% |
CMI -37% |
EMR -84% |
Quarterly Revenue Growth | 4% | 6/11 | XYL 26% |
EMR 11% |
ETN 8% |
IR 7% |
AOS 7% |
DOV 4% |
CMI 2% |
PNR 2% |
PH 2% |
ITW -1% |
FELE -5% |
Annual Revenue Growth | 2% | 5/11 | EMR 11% |
ETN 8% |
IR 7% |
XYL 5% |
DOV 2% |
AOS 2% |
CMI 1% |
FELE 0% |
ITW -1% |
PNR -1% |
PH -2% |
Cash On Hand | $328.8 Million | 8/11 | EMR $2.3B |
CMI $1.6B |
IR $1.1B |
ITW $862.0M |
XYL $815.0M |
ETN $540.0M |
PH $422.0M |
DOV $328.8M |
AOS $216.1M |
PNR $214.3M |
FELE $58.1M |
Short Term Debt | $210.5 Million | 6/11 | PH $3.4B |
EMR $3.1B |
CMI $2.2B |
ITW $2.0B |
ETN $1.3B |
DOV $210.5M |
XYL $123.0M |
FELE $60.6M |
IR $51.6M |
PNR $28.8M |
AOS $10.0M |
Long Term Debt | $3.0 Billion | 7/11 | ETN $8.6B |
PH $7.2B |
EMR $7.1B |
ITW $6.4B |
CMI $5.3B |
IR $4.8B |
DOV $3.0B |
XYL $2.0B |
PNR $1.8B |
AOS $130.4M |
FELE $87.2M |
PE | 17.44 | 11/11 | IR 48.86 |
XYL 42.67 |
EMR 37.08 |
ETN 35.76 |
PH 28.39 |
ITW 25.35 |
FELE 25.14 |
PNR 23.84 |
CMI 22.92 |
AOS 22.28 |
DOV 17.44 |
PS | 3.07 | 9/11 | IR 5.73 |
ETN 5.41 |
XYL 5.13 |
ITW 4.86 |
PH 4.05 |
PNR 3.83 |
EMR 3.73 |
AOS 3.27 |
DOV 3.07 |
FELE 2.35 |
CMI 1.30 |
PB | 4.88 | 5/11 | ITW 26.25 |
ETN 6.78 |
AOS 6.72 |
PH 6.68 |
DOV 4.88 |
PNR 4.58 |
CMI 4.21 |
IR 4.02 |
FELE 3.86 |
XYL 3.15 |
EMR 2.37 |
PC | 79.56 | 5/11 | ETN 241.80 |
PH 191.32 |
ITW 90.20 |
FELE 81.53 |
DOV 79.56 |
PNR 73.37 |
AOS 59.43 |
XYL 40.05 |
IR 37.95 |
CMI 28.02 |
EMR 27.53 |
Liabilities to Equity | 1.11 | 4/11 | ITW 4.26 |
CMI 2.17 |
PH 1.43 |
DOV 1.11 |
ETN 1.05 |
EMR 0.91 |
PNR 0.91 |
IR 0.78 |
AOS 0.67 |
XYL 0.52 |
FELE 0.46 |
ROA | 0.13 | 3/11 | ITW 20% | AOS 18% | DOV 13% | FELE 11% | PNR 10% | PH 10% | ETN 9% | CMI 6% | IR 5% | XYL 5% | EMR 4% |
ROE | 0.28 | 3/11 | ITW 104% |
AOS 30% |
DOV 28% |
PH 24% |
CMI 20% |
ETN 19% |
PNR 19% |
FELE 15% |
EMR 8% |
IR 8% |
XYL 7% |
Current Ratio | 1.90 | 8/11 | FELE 3.20 |
XYL 2.91 |
AOS 2.49 |
EMR 2.41 |
IR 2.28 |
PNR 2.10 |
ETN 1.96 |
DOV 1.90 |
PH 1.70 |
CMI 1.51 |
ITW 1.23 |
Quick Ratio | 0.06 | 10/11 | IR 48.86 |
XYL 42.67 |
EMR 37.08 |
ETN 35.76 |
PH 28.39 |
ITW 25.35 |
FELE 25.14 |
PNR 23.84 |
CMI 22.92 |
AOS 22.28 |
DOV 17.44 |
Long Term Debt to Equity | 0.55 | 4/11 | ITW} 2.17 |
PH} 0.59 |
CMI} 0.56 |
DOV} 0.55 |
PNR} 0.51 |
IR} 0.48 |
ETN} 0.45 |
EMR} 0.34 |
XYL} 0.19 |
AOS} 0.07 |
FELE} 0.07 |
Debt to Equity | 0.59 | 4/11 | ITW 2.86 |
PH 0.87 |
CMI 0.83 |
DOV 0.59 |
ETN 0.55 |
PNR 0.55 |
EMR 0.52 |
IR 0.48 |
XYL 0.20 |
FELE 0.16 |
AOS 0.09 |
Burn Rate | -2.97 | 10/11 | ITW 94.10 |
IR 59.24 |
CMI 41.71 |
EMR 3.10 |
PH 1.20 |
FELE -1.44 |
AOS -1.46 |
ETN -1.63 |
PNR -1.97 |
DOV -2.97 |
XYL -9.70 |
Cash to Cap | 0.01 | 6/11 | EMR 0.04 |
CMI 0.04 |
IR 0.03 |
AOS 0.02 |
XYL 0.02 |
DOV 0.01 |
ITW 0.01 |
PNR 0.01 |
PH 0.01 |
FELE 0.01 |
ETN 0.00 |
CCR | 0.58 | 8/11 | EMR 3.03 |
PNR 2.81 |
IR 1.53 |
PH 1.43 |
XYL 1.11 |
ETN 0.76 |
ITW 0.75 |
DOV 0.58 |
FELE 0.44 |
AOS 0.22 |
CMI -1.50 |
EV to EBITDA | 62.47 | 6/11 | ETN} 97.32 |
IR} 92.32 |
XYL} 80.78 |
ITW} 74.04 |
PH} 71.21 |
DOV} 62.47 |
EMR} 59.28 |
PNR} 59.16 |
AOS} 56.52 |
FELE} 52.35 |
CMI} 41.84 |
EV to Revenue | 3.40 | 8/11 | IR 6.26 |
ETN 5.82 |
ITW 5.33 |
XYL 5.33 |
PH 4.56 |
EMR 4.23 |
PNR 4.23 |
DOV 3.40 |
AOS 3.26 |
FELE 2.42 |
CMI 1.49 |